Kyntra Bio (KYNB) EBT Margin (2014 - 2026)
Kyntra Bio (KYNB) reported EBT Margin of 812.28% for Q2 2026, up 1834.16 percentage points from -1021.88% a year earlier and up 1217.09 percentage points from the prior quarter.
Kyntra Bio (KYNB) EBT Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kyntra Bio's EBT Margin came in at -408.66%, up 782.51 percentage points year-over-year; for FY2025, it came in at -905.19%, down 387.42 percentage points from FY2024.
- EBT Margin has a five-year change of -798.15 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -517.76% in FY2024 (+172.84 pp), -690.60% in FY2023 (-481.08 pp), -209.52% in FY2022 (-85.99 pp) and -123.53% in FY2021 (-16.49 pp).
- The Q2 2026 figure ranks as the highest quarterly EBT Margin in data going back to Q1 2014.
- Year over year, EBT Margin gained in four of the last seven quarters, with an average year-over-year change of +488.34 percentage points.
- The high point for year-over-year EBT Margin in five years was Q3 2025 (a gain of 38037.60 percentage points); the low point was Q3 2024 (a drop of 39099.37 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -404.82% (Q1 2026), -1144.09% (Q4 2025) and -1221.75% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | -4.34% |
| 10 | Kyntra Bio | 21.09 Mn | -386.85 Mn | 1.47 Mn | 812.28% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 812.28% |
| Mar 31, 2026 | -404.82% |
| Dec 31, 2025 | -1,144.09% |
| Sep 30, 2025 | -1,221.75% |
| Jun 30, 2025 | -1,021.88% |
| Mar 31, 2025 | -612.05% |
| Dec 31, 2024 | -276.33% |
| Sep 30, 2024 | -39,259.35% |
| Jun 30, 2024 | -4,747.09% |
| Mar 31, 2024 | -193.34% |
| Sep 30, 2023 | -159.98% |
| Jun 30, 2023 | -199.61% |
| Mar 31, 2023 | -214.12% |
| Dec 31, 2022 | -193.05% |
| Sep 30, 2022 | -584.32% |
| Jun 30, 2022 | -245.47% |
| Mar 31, 2022 | -104.25% |
| Dec 31, 2021 | -811.88% |
| Sep 30, 2021 | 31.78% |
| Jun 30, 2021 | -552.26% |
Kyntra Bio EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=KYNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();